NIH-funded research R01 grant

Understanding how host factors influence the replication of herpes simplex virus

Official title: ROLES OF HOST FACTORS IN VIRAL REPLICATION COUPLED PROCESSES

Funded at Duquesne University · NIH-11015063 · Data updated 2026-11-12

This study is looking at how the herpes virus makes copies of its DNA and how it works with our body's cells, with the hope of finding new ways to treat herpes infections better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionDuquesne University
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startFebruary 7, 2022
Project endJanuary 31, 2027
Funding year2025
Award (this year)$334,650
NIH project number5R01AI158361-04
Project IDNIH-11015063 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals infected with herpes simplex virus, particularly those experiencing recurrent outbreaks or antiviral resistance.

Less likely to help

Patients who do not have herpes simplex virus infections or those with other unrelated viral infections may not benefit from this research.

What this research studies

This research investigates the molecular mechanisms by which herpes simplex virus (HSV) replicates its DNA and how it interacts with host cellular factors. By using advanced proteomic and genome-wide assays, the study aims to uncover how HSV-1 coordinates its DNA synthesis with the host's DNA repair and transcription processes. Patients may benefit from insights gained into potential new antiviral therapies that target these interactions, ultimately improving treatment options for herpes infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of more effective antiviral therapies for herpes simplex virus infections.

How similar studies have gone: Previous research has shown success in understanding viral replication mechanisms, suggesting that this approach could yield valuable insights.

Where this research is happening

  • Duquesne University
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Dembowski, Jill Ann — Duquesne University
  • Study coordinator: Dembowski, Jill Ann

Related research

Other NIH-funded projects on the same topics.

  • Genes essential for egg function and fertilization

    Researchers are studying how eggs become ready to fertilize and trigger embryo development, using a worm model to uncover key egg-side Molecules that could inform fertility and birth control research for adults.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11619389

  • Systemic travel of damaged DNA in autoimmune skin disorders

    A research project looks at tiny particles shed from UV-damaged skin that carry damaged DNA and travel through the body, potentially worsening autoimmune inflammation in people with photosensitive conditions like lupus.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11537827

  • Injectable 3D Tissues to Support Regulatory T Cells for Better Allograft Tolerance

    This grant explores a new injectable 3D cell therapy approach to help regulate the immune system and reduce transplant rejection in people who receive organ transplants.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11350997

  • Mosquito bacteria designed to block malaria spread

    Researchers are modifying harmless bacteria inside mosquitoes so the bugs can't pass malaria to people.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11323096

  • How human cell proteins help herpes simplex virus copy and repair its DNA

    The team is identifying how human cell proteins interact with herpes simplex virus DNA during copying, repair, and gene activation to guide future treatments for people with HSV infections.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11261202

  • Restoring the brain's cleanup cells to help in Lewy body disease

    This project looks at whether removing and then regrowing the brain's immune cells can help clear harmful protein clumps that damage people with Lewy body disease.

    NIH research Duquesne University · Pittsburgh, United States · NIH-11194408

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.